{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/27/3263711/0/en/Press-Release-Sanofi-s-Sarclisa-subcutaneous-formulation-administered-via-on-body-injector-recommended-for-EU-approval-by-the-CHMP-to-treat-multiple-myeloma.html", "message": "News view counter 628812 successfully enlarged"}